cgp 12177 has been researched along with Hypersensitivity in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pelucchi, A | 1 |
| Sher, E | 1 |
| Mastropasqua, B | 1 |
| Diedenhofen, A | 1 |
| Mazza, P | 1 |
| Cavigioli, G | 1 |
| Marazzini, L | 1 |
1 other study available for cgp 12177 and Hypersensitivity
| Article | Year |
|---|---|
Effect of salbutamol on potassium influx in erythrocytes of allergic subjects and investigation of beta 2 receptor autoantibodies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Antibodies, Monoclonal; Ast | 1990 |